Cathie Wood’s ARK Invest Buys Over 350,000 Shares of Pfizer

One ARK Invest exchange-traded fund run by ETF star Cathie Wood bought over 350,000 shares of Pfizer Inc. (NYSE: PFE) on Friday, as the price of this fund was up over 2% in the day’s session. It is also up a fair amount in the past year.

ARK Genomic Revolution ETF (NYSEARCA: ARKG) added 351,289 shares of Pfizer. At Friday’s closing price, this would have valued this purchase at roughly $16.4 million. This is only a small fraction of the total holdings. The fund is up 42% over the past 52 weeks.

Check out all the ARK Invest buys for Friday:

FundTickerNameShares
ARKFJDJD.COM38,130
ARKFPDDPINDUODUO62,767
ARKFTDOCTELADOC HEALTH4,793
ARKGPFEPFIZER351,289
ARKGQSIQUANTUM-SI1,818
ARKGFATEFATE THERAPEUTICS57,841
ARKGDYNSDYNAMICS SPECIAL PURPOSE49,500
ARKGRPTXREPARE THERAPEUTICS7,501
ARKGADPTADAPTIVE BIOTECHNOLOGIES1,000
ARKGPSNLPERSONALIS5,444
ARKKSGFYSIGNIFY HEALTH190,400
ARKKFATEFATE THERAPEUTICS114,617
ARKQACICATLAS CREST INVESTMENT190,900
ARKQKTOSKRATOS DEFENSE & SECURITY SOLUTIONS59,400
ARKQKMTUYKOMATSU17,000
ARKWGENIGENIUS SPORTS69,647
ARKXPRNT3D PRINTING ETF11,293

Catherine Wood, the CEO and CIO of ARK Investment Management, is a minority and nonvoting shareholder of 24/7 Wall St.

Source: Read Full Article